Type 1 diabetes remains the most common endocrine disease in childhood, with incidence rates rising globally. The 2018 Clinical Practice Guidelines stress that management in this population is uniquely complex, requiring a delicate balance between achieving strict glycemic targets to prevent long-term complications and minimizing the immediate risks of hypoglycemia and diabetic ketoacidosis (DKA).
This practice exam tests your ability to navigate these challenges, from selecting appropriate insulin regimens to managing acute complications and screening for associated autoimmune conditions.
Key Concepts Covered in This Exam:
Therapeutic Targets: Mastering the recommendation to aim for an A1C <7.5% across all pediatric age groups, while acknowledging that targets must be individualized based on hypoglycemia risk.
Insulin Regimens: Identifying basal-bolus therapy (MDI) or continuous subcutaneous insulin infusion (CSII/pumps) as the gold standard treatments for optimizing control and flexibility.
DKA Management: Understanding the critical protocols for treating diabetic ketoacidosis, including the cautious use of fluids and insulin to prevent cerebral edema, the leading cause of mortality in pediatric DKA.
Monitoring: Recognizing the need for frequent glucose monitoring (6 to 10 times daily) or the use of Continuous Glucose Monitoring (CGM) to safely manage variability.
Comorbidity Screening: Recalling the schedule for screening associated autoimmune diseases, specifically hypothyroidism (at diagnosis and every 2 years) and celiac disease (at diagnosis and symptomatic intervals).
